/akn/sg/act/sub_leg/2007/HPA-S330-2016

Health Products (Licensing of Retail Pharmacies) Regulations 2016

The full official text, structured for quick navigation. Copy any provision or jump straight to a section.

Open source PDF
Type
Subsidiary Legislation
Status
In force
Enacted
2007
Sections
9

Quick answer

About this subsidiary legislation

Health Products (Licensing of Retail Pharmacies) Regulations 2016 is Singapore Subsidiary Legislation, cited as Subsidiary Legislation HPA-S330-2016 2007, currently marked in force and first recorded in 2007.

Regulation 1

Citation and commencement

Open as pageSuggest a correction

These Regulations are the Health Products (Licensing of Retail Pharmacies) Regulations 2016 and come into operation on 1 November 2016.

Regulation 2

Definitions

Open as pageSuggest a correction
Amended byS 455/2022 wef 01/07/2022S 433/2023 wef 26/06/2023S 433/2023 wef 26/06/2023S 106/2021 wef 01/03/2021S 120/2018 wef 01/03/2018S 433/2023 wef 26/06/2023S 433/2023 wef 26/06/2023S 808/2023 wef 18/12/2023S 808/2023 wef 18/12/2023S 433/2023 wef 31/12/2021S 433/2023 wef 31/12/2021S 433/2023 wef 31/12/2021S 120/2018 wef 01/03/2018S 106/2021 wef 01/03/2021S 433/2023 wef 26/06/2023

In these Regulations, unless the context otherwise requires —“application fee” means the applicable application fee specified in the Fifth Schedule to the Health Products (Fees) Regulations 2022 (G.N. No. S 450/2022);“approved conveyance”, “approved permanent premises” and “permanent premises” have the meanings given by section 2(1) of the Healthcare Services Act 2020;“Authority’s website” means the Authority’s Internet website at http://www.hsa.gov.sg;“collaborative prescribing practitioner” has the meaning given by regulation 2 of the Healthcare Services (Collaborative Prescribing Service) Regulations 2023 (G.N. No. S 398/2023);“CTGT product” means a health product categorised as a cell, tissue or gene therapy product in the First Schedule to the Act;“dispense”, in relation to a therapeutic product, means to prepare and supply the therapeutic product to a patient, where the preparation and supply is made by —

(a)

a qualified practitioner or collaborative prescribing practitioner, or a person acting under the supervision of a qualified practitioner or collaborative prescribing practitioner; or

(b)

a qualified pharmacist or a person acting under the supervision of a qualified pharmacist; “general sale list medicine” means a therapeutic product registered under the classification of “general sale list medicine” in the Register of Health Products;“healthcare service licensee” means a person who holds a licence under the Healthcare Services Act 2020 to provide a licensable healthcare service;“in-store pharmaceutical officer” means —

(a)

a qualified pharmacist engaged or employed to provide pharmacy services at or from a retail pharmacy specified in a pharmacy licence; or

(b)

a person acting under the supervision of the qualified pharmacist mentioned in paragraph (a), when providing pharmacy services at or from the retail pharmacy mentioned in that paragraph;[Deleted by S 433/2023 wef 26/06/2023]“licensable healthcare service” has the meaning given by section 3(1) of the Healthcare Services Act 2020;[Deleted by S 808/2023 wef 18/12/2023][Deleted by S 808/2023 wef 18/12/2023]“oral dental gum” means a health product categorised as an oral dental gum in the First Schedule to the Act;“personnel”, in relation to a healthcare service licensee providing a licensable healthcare service, means any individual employed or engaged by the healthcare service licensee to assist the licensee in providing the licensable healthcare service;“pharmacy department”, in relation to a healthcare service licensee, means the part of any approved permanent premises, approved conveyance or temporary premises of the healthcare service licensee set aside for the supply, dispensing or compounding of therapeutic products on order or prescription to patients at the approved permanent premises, approved conveyance or temporary premises;“pharmacy licence” means a licence, issued by the Authority under these Regulations, to carry on a retail pharmacy business at or from the retail pharmacy specified in the licence;“qualified pharmacist” means a person who —

(a)

is registered as a pharmacist under the Pharmacists Registration Act 2007;

(b)

holds a valid practising certificate granted under section 23 of that Act; and

(c)

is in active practice as defined in regulation 2 of the Pharmacists Registration (Practising Certificates) Regulations 2008 (G.N. No. S 438/2008);“qualified practitioner” means —

(a)

a registered medical practitioner under the Medical Registration Act 1997; or

(b)

a registered dentist under the Dental Registration Act 1999 whose name appears in the first division of the Register of Dentists maintained and kept under section 13(1)(a) of that Act;“retail pharmacy” means any premises at or from which a retail pharmacy business is or is to be conducted, and excludes a pharmacy department;“retail pharmacy business” means a business (not being a professional practice carried out by a qualified practitioner or collaborative prescribing practitioner) that consists of or includes the provision of retail pharmacy services to the general public;“retail pharmacy services” means the sale or dispensing of one or more specified health products, whether or not accompanied by advice or counselling on the effective and safe use of those products;“specified health product” means a health product specified in the First Schedule;“telepharmacy services” means the provision of retail pharmacy services by a qualified pharmacist at a retail pharmacy, through a computer, or video or audio link;“temporary premises” means any premises other than permanent premises;“therapeutic product” means a health product categorised as a therapeutic product in the First Schedule to the Act.

Definition

“application fee” means the applicable application fee specified in the Fifth Schedule to the Health Products (Fees) Regulations 2022 (G.N. No. S 450/2022);

Amended byS 455/2022 wef 01/07/2022
Suggest a correction

Definition

“approved conveyance”, “approved permanent premises” and “permanent premises” have the meanings given by section 2(1) of the Healthcare Services Act 2020;

Amended byS 433/2023 wef 26/06/2023
Suggest a correction

Definition

“Authority’s website” means the Authority’s Internet website at http://www.hsa.gov.sg;

Suggest a correction

Definition

“collaborative prescribing practitioner” has the meaning given by regulation 2 of the Healthcare Services (Collaborative Prescribing Service) Regulations 2023 (G.N. No. S 398/2023);

Amended byS 433/2023 wef 26/06/2023
Suggest a correction

Definition

“CTGT product” means a health product categorised as a cell, tissue or gene therapy product in the First Schedule to the Act;

Amended byS 106/2021 wef 01/03/2021
Suggest a correction

Definition

“dispense”, in relation to a therapeutic product, means to prepare and supply the therapeutic product to a patient, where the preparation and supply is made by —

(a)

a qualified practitioner or collaborative prescribing practitioner, or a person acting under the supervision of a qualified practitioner or collaborative prescribing practitioner; or

(b)

a qualified pharmacist or a person acting under the supervision of a qualified pharmacist;

Amended byS 120/2018 wef 01/03/2018
Suggest a correction

Definition

“general sale list medicine” means a therapeutic product registered under the classification of “general sale list medicine” in the Register of Health Products;

Suggest a correction

Definition

“healthcare service licensee” means a person who holds a licence under the Healthcare Services Act 2020 to provide a licensable healthcare service;

Amended byS 433/2023 wef 26/06/2023
Suggest a correction

Definition

“in-store pharmaceutical officer” means —

(a)

a qualified pharmacist engaged or employed to provide pharmacy services at or from a retail pharmacy specified in a pharmacy licence; or

(b)

a person acting under the supervision of the qualified pharmacist mentioned in paragraph (a), when providing pharmacy services at or from the retail pharmacy mentioned in that paragraph;

Suggest a correction

Definition

“licensable healthcare service” has the meaning given by section 3(1) of the Healthcare Services Act 2020;

Amended byS 433/2023 wef 26/06/2023
Suggest a correction

Definition

“oral dental gum” means a health product categorised as an oral dental gum in the First Schedule to the Act;

Suggest a correction

Definition

“personnel”, in relation to a healthcare service licensee providing a licensable healthcare service, means any individual employed or engaged by the healthcare service licensee to assist the licensee in providing the licensable healthcare service;

Amended byS 808/2023 wef 18/12/2023
Suggest a correction

Definition

“pharmacy department”, in relation to a healthcare service licensee, means the part of any approved permanent premises, approved conveyance or temporary premises of the healthcare service licensee set aside for the supply, dispensing or compounding of therapeutic products on order or prescription to patients at the approved permanent premises, approved conveyance or temporary premises;

Amended byS 808/2023 wef 18/12/2023
Suggest a correction

Definition

“pharmacy licence” means a licence, issued by the Authority under these Regulations, to carry on a retail pharmacy business at or from the retail pharmacy specified in the licence;

Suggest a correction

Definition

“qualified pharmacist” means a person who —

(a)

is registered as a pharmacist under the Pharmacists Registration Act 2007;

(b)

holds a valid practising certificate granted under section 23 of that Act; and

(c)

is in active practice as defined in regulation 2 of the Pharmacists Registration (Practising Certificates) Regulations 2008 (G.N. No. S 438/2008);

Amended byS 433/2023 wef 31/12/2021
Suggest a correction

Definition

“qualified practitioner” means —

(a)

a registered medical practitioner under the Medical Registration Act 1997; or

(b)

a registered dentist under the Dental Registration Act 1999 whose name appears in the first division of the Register of Dentists maintained and kept under section 13(1)(a) of that Act;

Amended byS 433/2023 wef 31/12/2021S 433/2023 wef 31/12/2021
Suggest a correction

Definition

“retail pharmacy” means any premises at or from which a retail pharmacy business is or is to be conducted, and excludes a pharmacy department;

Suggest a correction

Definition

“retail pharmacy business” means a business (not being a professional practice carried out by a qualified practitioner or collaborative prescribing practitioner) that consists of or includes the provision of retail pharmacy services to the general public;

Amended byS 120/2018 wef 01/03/2018
Suggest a correction

Definition

“retail pharmacy services” means the sale or dispensing of one or more specified health products, whether or not accompanied by advice or counselling on the effective and safe use of those products;

Suggest a correction

Definition

“specified health product” means a health product specified in the First Schedule;

Suggest a correction

Definition

“telepharmacy services” means the provision of retail pharmacy services by a qualified pharmacist at a retail pharmacy, through a computer, or video or audio link;

Amended byS 106/2021 wef 01/03/2021
Suggest a correction

Definition

“temporary premises” means any premises other than permanent premises;

Amended byS 433/2023 wef 26/06/2023
Suggest a correction

Definition

“therapeutic product” means a health product categorised as a therapeutic product in the First Schedule to the Act.

Suggest a correction

Regulation 3

Requirements for supply by retail sale of specified health products

Open as pageSuggest a correction
Amended byS 120/2018 wef 01/03/2018S 120/2018 wef 01/03/2018S 106/2021 wef 01/03/2021S 433/2023 wef 26/06/2023S 120/2018 wef 01/03/2018S 692/2024 wef 04/09/2024S 455/2022 wef 01/07/2022S 433/2023 wef 31/12/2021S 106/2021 wef 01/03/2021S 106/2021 wef 01/03/2021S 106/2021 wef 01/03/2021

Subregulation 1

Suggest a correction

For the purposes of section 17 of the Act, a person (P) must not supply by retail sale any specified health product, unless —

(a)

P is the holder of a pharmacy licence;

(b)

the supply of the specified health product is carried out at or from the retail pharmacy specified in the pharmacy licence —

(i)

by an in-store pharmaceutical officer; or

(ii)

in the absence of that officer, by a special mode with the prior approval of the Authority;

(c)

the supply of the specified health product is carried out under, and in accordance with the conditions of, the pharmacy licence;

(d)

a proper record of every supply of the specified health product is made by the in-store pharmaceutical officer mentioned in sub-paragraph (b)(i), or using that special mode of supply mentioned in sub-paragraph (b)(ii);

(e)

P keeps the record made under sub-paragraph (d) for at least 2 years after the date of the supply of the specified health product to which the record relates;

(f)

P ensures that only an in-store pharmaceutical officer may have access to specified health products (other than a controlled drug) stored at the retail pharmacy; and

(g)

P ensures that only a qualified pharmacist may have access to any controlled drug stored at the retail pharmacy.

Subregulation 2

Suggest a correction
Amended byS 120/2018 wef 01/03/2018S 120/2018 wef 01/03/2018S 106/2021 wef 01/03/2021

In addition to the requirements in paragraph (1), P must not supply by retail sale any prescription-only medicine, unless —

(a)

the prescription-only medicine is supplied —

(i)

to a patient in accordance with a valid prescription given by a qualified practitioner or collaborative prescribing practitioner; or

(ii)

in accordance with the oral or written instructions of a qualified practitioner or collaborative prescribing practitioner who undertakes, when giving the instructions, to give a valid prescription within 24 hours after giving the instructions; or

(b)

in the case of therapeutic products only, the prescription-only medicine supplied —

(i)

is specified in the list of prescription-only medicines exempted for limited sale and supply;

(ii)

is labelled to show a maximum daily dose not exceeding that specified in the list of prescription‑only medicines exempted for limited sale and supply;

(iii)

does not exceed the maximum supply specified in the list of prescription-only medicines exempted for limited sale and supply;

(iv)

is to a person who is of or above any minimum age specified in the list of prescription-only medicines exempted for limited sale and supply, and a record of the supply is made in accordance with regulation 16 of the Health Products (Therapeutic Products) Regulations 2016 (G.N. No. S 329/2016).

Subregulation 3

Suggest a correction
Amended byS 433/2023 wef 26/06/2023S 120/2018 wef 01/03/2018

To avoid doubt, paragraphs (1) and (2) do not apply to —

(a)

[Deleted by S 808/2023 wef 18/12/2023](aa)any of the following persons who supplies a specified health product by retail sale to a patient of a healthcare service licensee in accordance with the written instructions of a qualified practitioner or collaborative prescribing practitioner, who is a personnel of the healthcare service licensee:

(i)

the healthcare service licensee;

(ii)

a person who is authorised by the healthcare service licensee to make that supply; or

(b)

a qualified practitioner or collaborative prescribing practitioner, or a person acting in accordance with the oral or written instructions of a qualified practitioner or collaborative prescribing practitioner, supplying a specified health product to a patient under the care of the qualified practitioner or collaborative prescribing practitioner.

Subregulation 3A

Suggest a correction
Amended byS 692/2024 wef 04/09/2024

Paragraph (2) does not apply to a holder of a pharmacy licence in respect of —

(a)

the supply by retail sale of influenza vaccines in accordance with the conditions of such supply specified in item 2A of the Third Schedule to the Health Products (Therapeutic Products) Regulations 2016; or

(b)

the supply by retail sale of adrenaline administered using an autoinjector in accordance with the conditions of such supply specified in item 2B of the Third Schedule to the Health Products (Therapeutic Products) Regulations 2016.

Subregulation 4

Suggest a correction
Amended byS 455/2022 wef 01/07/2022

An application for the Authority’s approval under paragraph (1)(b)(ii) must —

(a)

be made in the form and manner specified on the Authority’s website; and

(b)

be accompanied by the application fee.

Subregulation 5

Suggest a correction
Amended byS 433/2023 wef 31/12/2021S 106/2021 wef 01/03/2021S 106/2021 wef 01/03/2021

In this regulation —

Definition

“controlled drug” has the same meaning as in section 2 of the Misuse of Drugs Act 1973;

Amended byS 433/2023 wef 31/12/2021
Suggest a correction

Definition

“list of prescription-only medicines exempted for limited sale and supply” means the list, as published on the Authority’s website, of therapeutic products classified as prescription‑only medicines that may be supplied at or from a retail pharmacy without the need for a valid prescription;

Suggest a correction

Definition

“prescription-only medicine” means a therapeutic product or a CTGT product registered under the classification of “prescription-only medicine” in the Register of Health Products;

Amended byS 106/2021 wef 01/03/2021
Suggest a correction

Definition

“valid prescription” means a prescription that is valid within the meaning in regulation 2(2) of the Health Products (Therapeutic Products) Regulations 2016 or regulation 2(2) of the Health Products (Cell, Tissue and Gene Therapy Products) Regulations 2021 (G.N. No. S 104/2021), as the case may be.

Amended byS 106/2021 wef 01/03/2021
Suggest a correction

Subregulation 6

Suggest a correction
Amended byS 106/2021 wef 01/03/2021

In relation to a collaborative prescribing practitioner mentioned in paragraphs (2)(a) and (3), references to prescription-only medicine in paragraph (2)(a) and specified health product in paragraph (3) are references to a therapeutic product only.

Regulation 4

Telepharmacy services

Open as pageSuggest a correction
Amended byS 455/2022 wef 01/07/2022

Subregulation 1

Suggest a correction

For the purposes of section 17 of the Act, a person must not supply any specified health product through telepharmacy services, unless the person —

(a)

is the holder of a pharmacy licence; (b)has obtained the Authority’s prior approval to provide telepharmacy services at or from the retail pharmacy specified in the pharmacy licence; and

(c)

complies with the conditions imposed by the Authority under paragraph (4).

Subregulation 2

Suggest a correction

The Authority may grant its approval for the holder of a pharmacy licence to supply specified health products through telepharmacy services at or from the retail pharmacy specified in the pharmacy licence, if all of the following requirements are satisfied:

(a)

the holder has the necessary technological set-up and capability for the delivery of the telepharmacy services;

(b)

the holder ensures there are adequately trained personnel to provide the telepharmacy services; (c)there are written procedures detailing how the telepharmacy services are to be provided.

Subregulation 3

Suggest a correction
Amended byS 455/2022 wef 01/07/2022

An application for the Authority’s approval under paragraph (1)(b) must —

(a)

be made in the form and manner specified on the Authority’s website; and

(b)

be accompanied by the application fee.

Subregulation 4

Suggest a correction

The Authority may grant its approval under paragraph (2), subject to any conditions that the Authority may impose, and the Authority’s approval and the conditions are to be endorsed on the pharmacy licence of the holder.

Subregulation 5

Suggest a correction

In determining whether to grant its approval under paragraph (2) for any telepharmacy service, the Authority may carry out an inspection of the retail pharmacy at or from which the telepharmacy services are to be provided.

Regulation 5

Application for pharmacy licence

Open as pageSuggest a correction
Amended byS 455/2022 wef 01/07/2022

For the purposes of section 24(2)(a)(i) of the Act, the Authority may issue a pharmacy licence in respect of a retail pharmacy to an applicant if all of the following requirements are satisfied:

(a)

the applicant has obtained all necessary approvals for the applicant’s retail pharmacy business from the relevant authorities, other than the Authority; (b)the retail pharmacy has a designated dispensing area which is sufficiently secure to prevent unauthorised access to the dispensing area during operating hours; (c)the layout of the retail pharmacy allows for the orderly arrangement of specified health products which are to be supplied or dispensed by retail at or from the retail pharmacy;

(d)

the retail pharmacy is sufficiently secure to ensure the safekeeping of the specified health products to be supplied or dispensed by retail at or from the retail pharmacy and to prevent unauthorised access to any specified health product at all times;

(e)

the retail pharmacy has appropriate storage facilities to store each specified health product in accordance with the conditions approved by the Authority for the storage of the specified health product; (f)an adequate system is in place for proper safekeeping and maintenance of records in respect of the specified health products stored at the retail pharmacy, including arrangements to audit the records to ensure their integrity; (g)the retail pharmacy will at all times be under the control and management of a qualified pharmacist; (h)the applicant has paid the application fee.

Regulation 6

Suspension and revocation of pharmacy licence and cancellation of approval

Open as pageSuggest a correction
Amended byS 433/2023 wef 31/12/2021S 433/2023 wef 31/12/2021S 433/2023 wef 31/12/2021S 433/2023 wef 31/12/2021

For the purposes of section 27(1)(b)(iii) of the Act, the Authority may suspend or revoke any pharmacy licence issued to a person, or cancel any approval granted to a person, if the person is convicted, whether before, on or after 1 November 2016, of an offence under any of the following Acts or subsidiary legislation made under those Acts:

(a)

the Medicines Act 1975;

(b)

the Misuse of Drugs Act 1973;

(c)

the Pharmacists Registration Act 2007;

(d)

the Poisons Act 1938.

Regulation 7

Changes affecting pharmacy licence

Open as pageSuggest a correction
Amended byS 455/2022 wef 01/07/2022

Subregulation 1

Suggest a correction

Subject to paragraph (2), a holder of a pharmacy licence in respect of a retail pharmacy must not, without the prior approval of the Authority —

(a)

make any change to any matter the particulars of which are contained in the pharmacy licence or the holder’s application for the pharmacy licence; (b)make or cause any change to the layout or infrastructure of the retail pharmacy; or

(c)

make or cause any change in the conduct of the holder’s retail pharmacy business that the holder is approved to conduct at or from the retail pharmacy.

Subregulation 2

Suggest a correction

Despite paragraph (1), a holder of a pharmacy licence who is approved by the Authority to provide telepharmacy services under regulation 4 may make any change to the procedures for providing the telepharmacy services mentioned in regulation 4(2)(c), if the holder gives prior notice to the Authority of that change.

Subregulation 3

Suggest a correction
Amended byS 455/2022 wef 01/07/2022

An application for the Authority’s approval under paragraph (1) must —

(a)

be made in the form and manner specified on the Authority’s website; and

(b)

be accompanied by the application fee.

Subregulation 4

Suggest a correction

In determining whether to grant its approval under paragraph (1), the Authority may carry out an inspection of the retail pharmacy specified in the pharmacy licence.

Subregulation 5

Suggest a correction

Any holder of a pharmacy licence who contravenes paragraph (1) or (2) shall be guilty of an offence and shall be liable on conviction to a fine not exceeding $20,000 or to imprisonment for a term not exceeding 12 months or to both.

Regulation 8

Routine inspections

Open as pageSuggest a correction

The Authority may conduct routine inspections of any retail pharmacy to ensure that the provisions of the Act and these Regulations are complied with.

Common questions

What is Health Products (Licensing of Retail Pharmacies) Regulations 2016?
Health Products (Licensing of Retail Pharmacies) Regulations 2016 is Singapore Subsidiary Legislation, cited as Subsidiary Legislation HPA-S330-2016 2007, currently marked in force and first recorded in 2007.
Is Health Products (Licensing of Retail Pharmacies) Regulations 2016 still in force?
Yes — Health Products (Licensing of Retail Pharmacies) Regulations 2016 is currently in force.
When did Health Products (Licensing of Retail Pharmacies) Regulations 2016 take effect?
Health Products (Licensing of Retail Pharmacies) Regulations 2016 was first recorded in 2007.
How many regulations does Health Products (Licensing of Retail Pharmacies) Regulations 2016 have?
Health Products (Licensing of Retail Pharmacies) Regulations 2016 contains 9 regulations.
Where can I read the official version of Health Products (Licensing of Retail Pharmacies) Regulations 2016?
The official text of Health Products (Licensing of Retail Pharmacies) Regulations 2016 is published at sso.agc.gov.sg.